;
Using data from the Taiwan National Health Insurance Research Database, Cheng-Yi Huang, MD, explains how he and Su-Chen Fang, PhD, and Yu-Hsuan Joni Shao, PhD, compared long-term effectiveness of switching to long-acting injectable antipsychotics versus remaining on oral antipsychotics.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.